A Multicenter Evaluation of Clopidogrel Resistance and Its Role in Predicting Stent Thrombosis in Transcarotid Artery Revascularization
Our multi-institutional cohort confirms a high rate of Clopidogrel resistance in patients undergoing TCAR, with higher acute stent thrombosis rates noted in patients with resistance. VerifyNow P2Y12 platelet reactivity assays more reliably predict Clopidogrel resistance than TEG-PM.
Authors
- Mimmie Kwong (ORCID: https://orcid.org/0000-0002-6283-0603)
- Sammy Siada (ORCID: https://orcid.org/0000-0002-0407-2883)
- Joel Harding
- Steven Maximus (ORCID: https://orcid.org/0000-0003-2819-1681)
- Kathryn DiLosa (ORCID: https://orcid.org/0000-0002-1984-5711)
- Katherine MacCallum (ORCID: https://orcid.org/0000-0003-4562-3263)
- Rachel Wolinsky
- Anjani Patibandla
Institutions
- Brown University (US)
- California State University, Fresno (US)
- University of California, Davis (US)
Publication Details
- Journal
- Annals of Vascular Surgery
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1016/j.avsg.2024.09.031
- Citations
- 2
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.80